GCC pharma summit highlights improvements in production and regulatory environment – ZAWYA

GCC pharma summit highlights improvements in production and regulatory environment – ZAWYA

GCC pharma summit highlights improvements in production and regulatory environment 5th Summit, supported by UAE Ministry of Health calls for stronger regional integration and focus on quality to maximise domestic and international opportunities    Dubai: Recent initiatives in Gulf countries to facilitate patient access to new medicines and the advantages of integrating regulations related to drug trials and registration regionwide were discussed at the GCC Regulatory Affairs Pharma Summit 2020, hosted in Dubai with the support of the UAE Ministry of Health and Prevention (MOHAP).The annual summit, now in its fifth year, was hosted online in view of the global alert against COVID-19, with representatives from the pharmaceuticals industry and healthcare administrations analyzing key drivers of regulatory reforms in the region.The importance of data and quality management in expediting drug registration and ensuring a safer community was also emphasized by the speakers, especially in the context of the COVID-19 crisis, which called for faster responses in terms of drug trials, approvals and import.The annual summit, now in its fifth year, was hosted online in view of the global alert against COVID-19, with representatives from the pharmaceuticals industry and healthcare administrations analyzing key drivers of regulatory reforms in the region.Dubai: Recent